These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 11570815

  • 1. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
    Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S.
    Exp Cell Res; 2001 Oct 01; 269(2):230-6. PubMed ID: 11570815
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
    Kim SJ, Min HY, Chung HJ, Park EJ, Hong JY, Kang YJ, Shin DH, Jeong LS, Lee SK.
    Cancer Lett; 2008 Jun 18; 264(2):309-15. PubMed ID: 18321638
    [Abstract] [Full Text] [Related]

  • 3. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS, Chung HJ, Lee HW, Jeong LS, Lee SK.
    Immunobiology; 2011 Sep 18; 216(9):997-1003. PubMed ID: 21514967
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.
    Ohana G, Bar-Yehuda S, Barer F, Fishman P.
    J Cell Physiol; 2001 Jan 18; 186(1):19-23. PubMed ID: 11147810
    [Abstract] [Full Text] [Related]

  • 5. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.
    Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G.
    J Cell Physiol; 2000 Jun 18; 183(3):393-8. PubMed ID: 10797314
    [Abstract] [Full Text] [Related]

  • 6. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
    Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, Madi L.
    Anticancer Res; 2003 Jun 18; 23(3A):2077-83. PubMed ID: 12894581
    [Abstract] [Full Text] [Related]

  • 7. A3 adenosine receptor as a target for cancer therapy.
    Fishman P, Bar-Yehuda S, Madi L, Cohn I.
    Anticancer Drugs; 2002 Jun 18; 13(5):437-43. PubMed ID: 12045454
    [Abstract] [Full Text] [Related]

  • 8. Activation of adenosine A(3) receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice.
    Hofer M, Pospísil M, Sefc L, Dusek L, Vacek A, Holá J, Hoferová Z, Streitová D.
    Int J Radiat Biol; 2010 Aug 18; 86(8):649-56. PubMed ID: 20586541
    [Abstract] [Full Text] [Related]

  • 9. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
    Lu J, Pierron A, Ravid K.
    Cancer Res; 2003 Oct 01; 63(19):6413-23. PubMed ID: 14559831
    [Abstract] [Full Text] [Related]

  • 10. Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression.
    Xaus J, Valledor AF, Cardó M, Marquès L, Beleta J, Palacios JM, Celada A.
    J Immunol; 1999 Oct 15; 163(8):4140-9. PubMed ID: 10510349
    [Abstract] [Full Text] [Related]

  • 11. Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells.
    Hofer M, Pospísil M, Znojil V, Holá J, Streitová D, Vacek A.
    Exp Biol Med (Maywood); 2008 Jul 15; 233(7):897-900. PubMed ID: 18445770
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
    Shneyvays V, Nawrath H, Jacobson KA, Shainberg A.
    Exp Cell Res; 1998 Sep 15; 243(2):383-97. PubMed ID: 9743598
    [Abstract] [Full Text] [Related]

  • 13. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A.
    J Cell Physiol; 2009 Nov 15; 221(2):378-86. PubMed ID: 19562684
    [Abstract] [Full Text] [Related]

  • 14. Effects of adenosine A(3) receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice.
    Hofer M, Pospísil M, Vacek A, Holá J, Znojil V, Weiterová L, Streitová D.
    Eur J Pharmacol; 2006 May 24; 538(1-3):163-7. PubMed ID: 16643889
    [Abstract] [Full Text] [Related]

  • 15. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
    Gessi S, Merighi S, Varani K, Cattabriga E, Benini A, Mirandola P, Leung E, Mac Lennan S, Feo C, Baraldi S, Borea PA.
    J Cell Physiol; 2007 Jun 24; 211(3):826-36. PubMed ID: 17348028
    [Abstract] [Full Text] [Related]

  • 16. Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes.
    Wittendorp MC, Boddeke HW, Biber K.
    Glia; 2004 May 24; 46(4):410-8. PubMed ID: 15095371
    [Abstract] [Full Text] [Related]

  • 17. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
    Panjehpour M, Karami-Tehrani F.
    Int J Biochem Cell Biol; 2004 Aug 24; 36(8):1502-9. PubMed ID: 15147729
    [Abstract] [Full Text] [Related]

  • 18. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P, Dolezel P, Kosztyu P.
    J Cell Physiol; 2012 Feb 24; 227(2):676-85. PubMed ID: 21520073
    [Abstract] [Full Text] [Related]

  • 19. Adenosine A(3) receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis.
    Hofer M, Pospísil M, Znojil V, Holá J, Vacek A, Streitová D.
    Biomed Pharmacother; 2007 Jul 24; 61(6):356-9. PubMed ID: 17383145
    [Abstract] [Full Text] [Related]

  • 20. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors.
    Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I.
    Circ Res; 2003 Mar 21; 92(5):485-92. PubMed ID: 12600879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.